Journal article icon

Journal article

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.

Abstract:

BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms of burden for individual sufferers, their families and society as a whole. Recently, dualacting antidepressants, which block both serotonin (5-HT) and noradrenaline (NA) reuptake, have been developed with the hope of improving depression treatment outcomes. Duloxetine is a dual reuptake inhibitor of 5-HT and NA that has recently been licensed in the USA for the treatment of MDD. OBJECTIVE: This...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1185/030079905x30680

Authors


Ogilvie, AD More by this author
Journal:
Current medical research and opinion
Volume:
21
Issue:
3
Pages:
345-356
Publication date:
2005-03-05
DOI:
EISSN:
1473-4877
ISSN:
0300-7995
URN:
uuid:48624e5a-0472-4e3a-b941-66846a7976aa
Source identifiers:
139906
Local pid:
pubs:139906

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP